S1PR1 mediates anti‑apoptotic/pro‑proliferative processes in human acute myeloid leukemia cells

Xu,Xiao‑Qian; Huang,Chong‑Mei; Zhang,Yi‑Fan; Chen,Li; Cheng,Hui; Wang,Jian‑Min

doi:10.3892/mmr.2016.5629

S1PR1 mediates anti‑apoptotic/pro‑proliferative processes in human acute myeloid leukemia cells

Authors:
- Xiao‑Qian Xu
- Chong‑Mei Huang
- Yi‑Fan Zhang
- Li Chen
- Hui Cheng
- Jian‑Min Wang
View Affiliations

Affiliations: Department of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China, Department of Nuclear Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, P.R. China
Published online on: August 12, 2016 https://doi.org/10.3892/mmr.2016.5629
Pages: 3369-3375

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sphingosine-1-phosphate receptor 1 (S1PR1), the G protein-coupled receptor 1 of sphingosine 1-phosphate (S1P), is crucial in the progression of various types of solid tumor through the positive regulation of anti‑apoptotic/pro‑survival responses by S1P‑S1PR1 signaling. However, the role of S1PR1 in the progression of human acute myeloid leukemia (AML) remains to be fully elucidated. In the present study, the correlation between the expression level of S1PR1 and the growth and apoptosis of human AML cells was investigated. Using overexpression and RNA interference knockdown assays, it was shown that the expression of S1PR1 in several human myeloid leukemia cell lines contributed to the suppression of cell apoptosis and promotion of cell proliferation. S1PR1 inhibited the expression level of B cell lymphoma‑2‑associated X protein, a mitochondrion‑associated apoptosis promoter, and prevented caspase‑3 cleavage, indicating that S1PR1 interfered with the mitochondrion‑associated apoptotic processes in AML cells. In addition, the present study demonstrated that S1PR1 suppressed the generation of reactive oxygen species (ROS) in AML cells, and that the apoptosis mediated by the downregulation of S1PR1 was partially reversed by treatment with N‑acetyl‑L‑cysteine, a ROS scavenging agent, suggesting that the S1PR1‑induced resistance of cell apoptosis resulted, at least partially, from the suppression of ROS generation. Additionally, S1PR1 was able to interfere with the signaling of c‑Jun N‑terminal kinase, which may have also contribute dto the suppression of cell apoptosis. By contrast, extracellular signal‑regulated kinase (ERK) signaling appeared to be positively modulated by the S1PR1‑induced enhancement of mitogen‑activated protein kinase (MAPK) kinase 1 (MKK1) activation, suggesting that S1PR1 may promote cell survival and proliferation through enhancing the activation of MKK1‑ERK signaling. In conclusion, S1PR1 likely serves as an anti‑apoptotic/pro‑proliferative protein in AML cells through the inhibition of mitochondrion‑associated apoptosis and ROS generation, and via the regulation of multiple MAPK signaling cascades.

View Figures

View References

1	Pyne NJ and Pyne S: Sphingosine 1-phosphate and cancer. Nat Rev Cancer. 10:489–503. 2010. View Article : Google Scholar : PubMed/NCBI
2	Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A, Kortylewski M, Horne D, Somlo G, Forman S, et al: STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med. 16:1421–1428. 2010. View Article : Google Scholar : PubMed/NCBI
3	Chae SS, Paik JH, Furneaux H and Hla T: Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest. 114:1082–1089. 2004. View Article : Google Scholar : PubMed/NCBI
4	Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK, et al: S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell. 21:642–654. 2012. View Article : Google Scholar : PubMed/NCBI
5	Yoshida Y, Nakada M, Harada T, Tanaka S, Furuta T, Hayashi Y, Kita D, Uchiyama N, Hayashi Y and Hamada J: The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients. J Neurooncol. 98:41–47. 2010. View Article : Google Scholar
6	Matsuoka Y, Nagahara Y, Ikekita M and Shinomiya T: A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. Br J Pharmacol. 138:1303–1312. 2003. View Article : Google Scholar : PubMed/NCBI
7	Wang JD, Takahara S, Nonomura N, Ichimaru N, Toki K, Azuma H, Matsumiya K, Okuyama A and Suzuki S: Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation. Prostate. 40:50–55. 1999. View Article : Google Scholar : PubMed/NCBI
8	Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, Kulp SK, Muthusamy N, Byrd JC, Cheng AL and Chen CS: FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Res. 68:1204–1212. 2008. View Article : Google Scholar : PubMed/NCBI
9	Adams JM: Ways of dying: Multiple pathways to apoptosis. Genes Dev. 17:2481–2495. 2003. View Article : Google Scholar : PubMed/NCBI
10	Fiers W, Beyaert R, Declercq W and Vandenabeele P: More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene. 18:7719–7730. 1999. View Article : Google Scholar
11	Simon HU, Haj-Yehia A and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5:415–418. 2000. View Article : Google Scholar
12	Fiers W, Beyaert R, Declercq W and Vandenabeele P: More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene. 18:7719–7730. 1999. View Article : Google Scholar
13	Chen YR, Shrivastava A and Tan TH: Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate. Oncogene. 20:367–374. 2001. View Article : Google Scholar : PubMed/NCBI
14	Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y, Piao JH, Yagita H, Okumura K, Doi T and Nakano H: NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22:3898–3909. 2003. View Article : Google Scholar : PubMed/NCBI
15	Kamata H, Honda S, Maeda S, Chang L, Hirata H and Karin M: Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 120:649–661. 2005. View Article : Google Scholar : PubMed/NCBI
16	Grigoryev S, Salzberg A, Berg A, Harris-Becker A, Loughran T and Claxton D: Genome-wide mapping of large organized heterochromatin domains reveals hotspots of epigenetic and transcriptional changes associated with myeloid differentiation and acute myeloid leukemia (565.1). The FASEB Journal. 28:565.5612014.
17	Sarkisyan G, Gay LJ, Nguyen N, Felding BH and Rosen H: Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth. Am J Physiol Cell Physiol. 307:C14–C24. 2014. View Article : Google Scholar : PubMed/NCBI
18	Hamidi S, Schäfer-Korting M and Weindl G: TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts. Biochim Biophys Acta. 1841:484–494. 2014. View Article : Google Scholar : PubMed/NCBI
19	Wang T, Chen F, Chen Z, Wu YF, Xu XL, Zheng S and He X: Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol. 10:2205–2208. 2004.PubMed/NCBI
20	Jabs T: Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol. 57:231–245. 1999. View Article : Google Scholar : PubMed/NCBI
21	Cai J and Jones DP: Mitochondrial redox signaling during apoptosis. J Bioenerg Biomembr. 31:327–334. 1999. View Article : Google Scholar
22	Cristóbal I, Blanco FJ, Garcia-Orti L, Marcotegui N, Vicente C, Rifon J, Novo FJ, Bandres E, Calasanz MJ, Bernabeu C and Odero MD: SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia. Blood. 115:615–625. 2010. View Article : Google Scholar
23	Adams J and Cory S: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 26:1324–1337. 2007. View Article : Google Scholar : PubMed/NCBI
24	Pagès G, Lenormand P, L'Allemain G, Chambard JC, Meloche S and Pouysségur J: Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA. 90:8319–8323. 1993. View Article : Google Scholar : PubMed/NCBI
25	Rubinfeld H and Seger R: The ERK cascade: A prototype of MAPK signaling. Mol Biotechnol. 31:151–174. 2005. View Article : Google Scholar : PubMed/NCBI
26	Seger R and Krebs EG: The MAPK signaling cascade. FASEB J. 9:726–735. 1995.PubMed/NCBI
27	Chalah A and Khosravi-Far R: The mitochondrial death pathway. Adv Exp Med Biol. 615:25–45. 2008. View Article : Google Scholar : PubMed/NCBI